A task force formed within the CDC's Advisory Committee on Immunization Practices to discuss Covid-19 vaccines will be led by ...

The COVID-19 BNT162b2 vaccine was protective against COVID-19-associated hospitalization for the 2024 to 2025 season among immunocompetent adults.

The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...

Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...

The Trump administration may remove the COVID-19 vaccine from the US market within months, amid legal battles and data ...

The CDC has already changed some vaccine guidelines, and the FDA may change others, which could throw insurance coverage into ...

Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

The health and human services secretary, Robert F. Kennedy Jr., is accusing the American Academy of Pediatrics of a ...

The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 13596.29 with a total volume of 13,024.00. In the following chart, we are able to follow the development ...

While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.